Australia markets closed

Caribou Biosciences, Inc. (CRBU)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.3900-0.2000 (-5.57%)
At close: 04:00PM EDT
3.6000 +0.21 (+6.19%)
After hours: 05:25PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
33,404
34,477
13,851
9,598
12,361
Operating expenses
Research development
120,154
112,075
82,230
52,255
34,425
Selling general and administrative
44,195
38,461
38,020
24,322
14,060
Total operating expenses
164,349
150,536
120,250
76,577
48,485
Operating income or loss
-130,945
-116,059
-106,399
-66,979
-36,124
Interest expense
-
-
-
8
20
Total other income/expenses net
15,878
14,182
7,048
377
-219
Income before tax
-115,067
-101,877
-99,351
-66,602
-36,127
Income tax expense
-
193
70
321
-1,819
Income from continuing operations
-115,260
-102,070
-99,421
-66,923
-34,308
Net income
-115,260
-102,070
-99,421
-66,923
-34,308
Net income available to common shareholders
-115,260
-102,070
-99,421
-66,923
-34,308
Basic EPS
-1.43
-
-1.64
-2.11
-1.24
Diluted EPS
-1.43
-
-1.64
-2.11
-1.24
Basic average shares
66,912
-
60,801
31,663
27,657
Diluted average shares
66,912
-
60,801
31,663
27,657